Log in

NASDAQ:ADROAduro BioTech SEC Filings & 10K Form

$2.54
+0.03 (+1.20 %)
(As of 04/6/2020 06:13 AM ET)
Add
Compare
Today's Range
$2.44
Now: $2.54
$2.58
50-Day Range
$2.01
MA: $2.95
$3.87
52-Week Range
$0.90
Now: $2.54
$4.59
Volume312,400 shs
Average Volume745,940 shs
Market Capitalization$205.13 million
P/E RatioN/A
Dividend YieldN/A
Beta0.32

SEC Filings

Aduro BioTech (NASDAQ:ADRO) SEC Filings

DateFilerForm TypeView
03/24/2020
3:21 PM
Aduro BioTech (Filer)
Form DEFA14A
03/24/2020
3:18 PM
Aduro BioTech (Filer)
Form DEF 14A
03/24/2020
3:15 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/20/2020
4:18 PM
Aduro BioTech (Issuer)
Greenman William Mariner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/20/2020
4:17 PM
Aduro BioTech (Issuer)
ISAACS STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/09/2020
3:16 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/26/2020
5:58 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
5:33 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
5:30 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
5:29 PM
Aduro BioTech (Issuer)
Templeman Blaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
5:29 PM
Aduro BioTech (Issuer)
ISAACS STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
5:28 PM
Aduro BioTech (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/24/2020
5:28 PM
Aduro BioTech (Issuer)
Ferber Celeste (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2020
8:28 AM
Aduro BioTech (Subject)
RENAISSANCE TECHNOLOGIES LLC (Filed by)
Form SC 13G
02/05/2020
10:26 AM
Aduro BioTech (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
02/04/2020
8:24 AM
Aduro BioTech (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G
01/29/2020
3:56 PM
Aduro BioTech (Issuer)
Kachioff William G (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/23/2020
3:47 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/13/2020
5:09 AM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/10/2020
5:05 AM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/06/2020
5:38 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
3:20 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/16/2019
3:14 PM
Aduro BioTech (Issuer)
Templeman Blaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:13 PM
Aduro BioTech (Issuer)
Ferber Celeste (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:13 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/16/2019
3:12 PM
Aduro BioTech (Issuer)
ISAACS STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/07/2019
3:15 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2019
3:12 PM
Aduro BioTech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
09/27/2019
3:30 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/18/2019
6:00 PM
Aduro BioTech (Issuer)
Haghighat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
5:34 PM
Aduro BioTech (Issuer)
Ferber Celeste (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
5:34 PM
Aduro BioTech (Issuer)
ISAACS STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
5:33 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/17/2019
5:32 PM
Aduro BioTech (Issuer)
Templeman Blaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2019
3:15 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/01/2019
3:11 PM
Aduro BioTech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
07/15/2019
5:40 PM
Aduro BioTech (Issuer)
WELCH JAMES H (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/15/2019
5:40 PM
Aduro BioTech (Issuer)
WELCH JAMES H (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/28/2019
4:07 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/24/2019
12:47 PM
Aduro BioTech (Subject)
Morningside Venture Investments Ltd (0001636810) (Filed by)
Form SC 13D/A
05/22/2019
6:04 PM
Aduro BioTech (Issuer)
Ferber Celeste (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:06 PM
Aduro BioTech (Issuer)
Haghighat Ross (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:05 PM
Aduro BioTech (Issuer)
Greenman William Mariner (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:05 PM
Aduro BioTech (Issuer)
KARBE FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:04 PM
Aduro BioTech (Issuer)
SHERWIN STEPHEN A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:03 PM
Aduro BioTech (Issuer)
OBrien Stephanie Monaghan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:02 PM
Aduro BioTech (Issuer)
Mack David Henry (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:02 PM
Aduro BioTech (Issuer)
Nuyten Dimitry SA (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/15/2019
6:01 PM
Aduro BioTech (Issuer)
Nuyten Dimitry SA (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
05/08/2019
6:42 PM
Aduro BioTech (Issuer)
KARBE FRANK (Reporting)
Form 3/A
05/07/2019
3:11 PM
Aduro BioTech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/03/2019
6:17 PM
Aduro BioTech (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
3:15 PM
Aduro BioTech (Issuer)
KARBE FRANK (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2019
3:14 PM
Aduro BioTech (Issuer)
KARBE FRANK (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
04/18/2019
3:11 PM
Aduro BioTech (Filer)
Form DEFA14A
04/18/2019
3:10 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/10/2019
6:09 PM
Aduro BioTech (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/29/2019
3:26 PM
Aduro BioTech (Filer)
Form DEFA14A
03/29/2019
3:22 PM
Aduro BioTech (Filer)
Form DEF 14A
03/29/2019
3:15 PM
Aduro BioTech (Filer)
Form 8-K/A
03/22/2019
2:28 PM
Aduro BioTech (Subject)
Morningside Venture Investments Ltd (0001636810) (Filed by)
Form SC 13D/A
03/21/2019
4:35 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/19/2019
9:39 AM
Aduro BioTech (Filer)
Form CT ORDER
02/27/2019
6:07 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/27/2019
3:37 PM
Aduro BioTech (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
02/27/2019
3:36 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/27/2019
3:35 PM
Aduro BioTech (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/27/2019
3:34 PM
Aduro BioTech (Filer)
Form 424B5
02/21/2019
3:45 PM
Aduro BioTech (Issuer)
Ferber Celeste (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
3:43 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
3:42 PM
Aduro BioTech (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
3:39 PM
Aduro BioTech (Issuer)
Templeman Blaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
3:39 PM
Aduro BioTech (Issuer)
ISAACS STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/21/2019
7:16 AM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/11/2019
10:55 AM
Aduro BioTech (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
02/08/2019
3:01 PM
Aduro BioTech (Subject)
HARVARD MANAGEMENT CO INC (Filed by)
Form SC 13G/A
02/07/2019
4:03 PM
Aduro BioTech (Issuer)
Ferber Celeste (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
01/22/2019
10:34 AM
Aduro BioTech (Subject)
JOHNSON & JOHNSON (Filed by)
Form SC 13G/A
01/10/2019
8:37 AM
Aduro BioTech (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
01/07/2019
7:02 AM
Aduro BioTech (Subject)
SINGER JAMES R (Filed by)
Form SC 13G/A
01/07/2019
5:16 AM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/31/2018
3:02 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/18/2018
3:18 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/14/2018
3:19 PM
Aduro BioTech (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:18 PM
Aduro BioTech (Issuer)
Templeman Blaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:17 PM
Aduro BioTech (Issuer)
ISAACS STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/14/2018
3:15 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/07/2018
3:44 PM
Aduro BioTech (Issuer)
Hoth Daniel Floyd JR (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/20/2018
6:58 PM
Aduro BioTech (Issuer)
Templeman Blaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/09/2018
6:41 AM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
3:15 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/30/2018
3:11 PM
Aduro BioTech (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/01/2018
3:01 PM
Aduro BioTech (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/25/2018
7:11 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/25/2018
7:10 PM
Aduro BioTech (Issuer)
Templeman Blaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
6:29 PM
Aduro BioTech (Issuer)
Templeman Blaine (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
6:28 PM
Aduro BioTech (Issuer)
van Elsas Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
6:27 PM
Aduro BioTech (Issuer)
Lew Jennifer (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
6:25 PM
Aduro BioTech (Issuer)
Sacks Natalie (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/14/2018
6:24 PM
Aduro BioTech (Issuer)
ISAACS STEPHEN T (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 4/6/2020 by MarketBeat.com Staff

Featured Article: Investing in Growth Stocks

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel